Brind.
  1. West Virginia University leads a consortium, including partners like the University of Pittsburgh and Carnegie Mellon University, to advance the RETI Engine.

Medicus Pharma received FDA clearance for its Phase 2b trial registration targeting the US patient population, utilizing technology licensed from a university.

2 reports, 1 independent Updated Sep 8
Gone quiet
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Medicus Pharma received FDA clearance for its Phase 2b trial registration targeting the US patient population, utilizing technology licensed from a university.

Who's involved

What this event is mainly about
Carnegie Mellon UniversityUniversity of Pittsburgh

How it developed

Newest first. Tap a step to see who reported it.
  1. FDA gives the green light for Medicus Pharma's Phase 2b trial to commence.1 source
  2. Medicus Pharma successfully transitions research from the consortium into commercial testing with FDA clearance.1 source

Keep exploring

Part of

West Virginia University leads a consortium, including partners like the University of Pittsburgh and Carnegie Mellon University, to advance the RETI Engine. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped